News
2019
Comments in response to CDC’s request for information on priority topics for the Community Preventive Services Task Force | NASH Alliance
Today’s health problems are tomorrow’s health crises | Axios
Boehringer builds out NASH pipeline with up to $870M deal with South Korea’s Yuhan | Endpoints News
Emricasan fails to meet primary endpoint in NASH-cirrhosis trial | Healio Hepatology
Zydus completes enrollment in trial of Lipaglyn for NAFLD, NASH | Healio Hepatology
Gilead, Novo Nordisk Announce Intent to Initiate Clinical Collaboration | Gilead Sciences
Obesity Plagues Hispanics And Blacks In Colorado, Nation’s ‘Healthiest’ State | Kaiser Health News
Obesity Epidemic Leads To A New Problem — And It Could Be Worth Billions | Investor’s Business Daily
2018
Risks for Most Cancers Higher with NAFLD | Medpage Today
Fatty liver expert: ‘We face a moral, ethical and medical imperative’ | Healio
Multiple Drugs Advance for Fatty Liver Disease | Medscape
Pfizer, Novartis tie up to target NASH in crowded field | Endpoints News
More than 1 in 3 adults eat fast food on a given day, CDC survey finds | Brett Molina, USA TODAY
2017
More than 1 in 3 adults eat fast food on a given day, CDC survey finds | Scott Harris, MedPage Today
German Researchers Propose New Lifestyle Intervention for NASH | Universität Mainz
Pipeline Review for NASH Drugs, July 2017 | ReportLinker
One Third of HIV/AIDS Patients Have NASH | Michael Carter, NAM
NASH Now Affecting 16 Million Americans | Lydia Ramsey, Business Insider
Allergan Extending R&D Pipeline to Include NASH | Zacks Equity Research, Nasdaq
Companies Race to Find NASH Cure | Anne Steele, Fox Business
J&J Launches Partnerships for NASH, RA, obesity | Chris Lieu, Biocentury
NASH drug development halted | Genetic Engineering & Biotechnology News
Viking Announces Promising Top Line Results for NASH | PR Newswire
miRNA Signatures Can Identify NASH Patients | Gastroenterology & Endoscopy News
Can-Fite Establishes Clinical Advisory Board for NASH | PR Newswire
Exercise Improves Fatty Liver Disease | Medical News Bulletin
Interview on Push for NASH Treatment Options | Investorideas.com
Albireo Wins 2 U.S. Patents to Treat NASH | Daniela Semedo, PhD., Liver Disease News
NASH market to increase forty-fold by 2026 | Juliet Preston, MedCity News
Inflammatory signature of nonalcoholic fatty liver disease | ScienceDaily
Early Study to Test Bioelectronic Treatment for NASH | Ines Martins, PhD., Liver Disease News
What is NASH?
Do you have questions or are you looking for more information?
Resources
Keep informed with industry related news and publications.
About NASH Alliance
Learn more about our clinical advisory team of experts.